• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA修饰在乳腺癌中的调控作用。

Regulatory roles of RNA modifications in breast cancer.

作者信息

Kumari Kanchan, Groza Paula, Aguilo Francesca

机构信息

Department of Molecular Biology, Umeå University, SE-901 85 Umeå, Sweden.

出版信息

NAR Cancer. 2021 Sep 16;3(3):zcab036. doi: 10.1093/narcan/zcab036. eCollection 2021 Sep.

DOI:10.1093/narcan/zcab036
PMID:34541538
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8445368/
Abstract

Collectively referred to as the epitranscriptome, RNA modifications play important roles in gene expression control regulating relevant cellular processes. In the last few decades, growing numbers of RNA modifications have been identified not only in abundant ribosomal (rRNA) and transfer RNA (tRNA) but also in messenger RNA (mRNA). In addition, many writers, erasers and readers that dynamically regulate the chemical marks have also been characterized. Correct deposition of RNA modifications is prerequisite for cellular homeostasis, and its alteration results in aberrant transcriptional programs that dictate human disease, including breast cancer, the most frequent female malignancy, and the leading cause of cancer-related death in women. In this review, we emphasize the major RNA modifications that are present in tRNA, rRNA and mRNA. We have categorized breast cancer-associated chemical marks and summarize their contribution to breast tumorigenesis. In addition, we describe less abundant tRNA modifications with related pathways implicated in breast cancer. Finally, we discuss current limitations and perspectives on epitranscriptomics for use in therapeutic strategies against breast and other cancers.

摘要

RNA修饰统称为表转录组,在调控相关细胞过程的基因表达控制中发挥着重要作用。在过去几十年里,越来越多的RNA修饰不仅在丰富的核糖体RNA(rRNA)和转运RNA(tRNA)中被发现,也在信使RNA(mRNA)中被发现。此外,许多动态调节化学标记的写入器、擦除器和读取器也已得到表征。RNA修饰的正确沉积是细胞稳态的先决条件,其改变会导致异常的转录程序,进而引发包括乳腺癌在内的人类疾病,乳腺癌是女性中最常见的恶性肿瘤,也是女性癌症相关死亡的主要原因。在本综述中,我们重点介绍了tRNA、rRNA和mRNA中存在的主要RNA修饰。我们对与乳腺癌相关的化学标记进行了分类,并总结了它们对乳腺肿瘤发生的作用。此外,我们描述了在乳腺癌中涉及的相关途径的丰度较低的tRNA修饰。最后,我们讨论了目前表转录组学在针对乳腺癌和其他癌症的治疗策略中的局限性和前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/bf1513fc6aa1/zcab036fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/89a26187ed99/zcab036gra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/c8fc57ed8b0b/zcab036fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/16cfe96a83db/zcab036fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/8658975a5774/zcab036fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/c5af08f2fd1b/zcab036fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/bf1513fc6aa1/zcab036fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/89a26187ed99/zcab036gra1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/c8fc57ed8b0b/zcab036fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/16cfe96a83db/zcab036fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/8658975a5774/zcab036fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/c5af08f2fd1b/zcab036fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0f4/8445368/bf1513fc6aa1/zcab036fig5.jpg

相似文献

1
Regulatory roles of RNA modifications in breast cancer.RNA修饰在乳腺癌中的调控作用。
NAR Cancer. 2021 Sep 16;3(3):zcab036. doi: 10.1093/narcan/zcab036. eCollection 2021 Sep.
2
A mark of disease: how mRNA modifications shape genetic and acquired pathologies.疾病的标志:mRNA 修饰如何影响遗传和获得性疾病。
RNA. 2021 Apr;27(4):367-389. doi: 10.1261/rna.077271.120. Epub 2020 Dec 29.
3
Messenger RNA Modifications in Plants.植物中的信使 RNA 修饰。
Trends Plant Sci. 2019 Apr;24(4):328-341. doi: 10.1016/j.tplants.2019.01.005. Epub 2019 Feb 8.
4
The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses.RNA 修饰的曲目编排了丰富多彩的细胞反应。
Int J Mol Sci. 2023 Jan 25;24(3):2387. doi: 10.3390/ijms24032387.
5
Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.解析细胞命运决定和发育中的表观转录组特征。
Stem Cell Rev Rep. 2019 Aug;15(4):474-496. doi: 10.1007/s12015-019-09894-3.
6
Environmental epitranscriptomics.环境表观转录组学。
Environ Res. 2020 Oct;189:109885. doi: 10.1016/j.envres.2020.109885. Epub 2020 Jul 11.
7
Shaping the Bacterial Epitranscriptome-5'-Terminal and Internal RNA Modifications.塑造细菌转录组-5'端和内部 RNA 修饰。
Adv Biol (Weinh). 2021 Aug;5(8):e2100834. doi: 10.1002/adbi.202100834. Epub 2021 Jun 14.
8
RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.RNA 修饰与表观遗传学在调控肺癌及肺部疾病中的作用。
Int J Mol Sci. 2021 Sep 30;22(19):10592. doi: 10.3390/ijms221910592.
9
Recent advances in the plant epitranscriptome.植物表观转录组的最新进展。
Genome Biol. 2023 Mar 7;24(1):43. doi: 10.1186/s13059-023-02872-6.
10
Exploring epitranscriptomics for crop improvement and environmental stress tolerance.探索表观转录组学在作物改良和环境胁迫耐受方面的应用。
Plant Physiol Biochem. 2022 Jul 15;183:56-71. doi: 10.1016/j.plaphy.2022.04.031. Epub 2022 May 7.

引用本文的文献

1
Analysis of the mRNA modification machinery alterations in breast cancer through the SCAN-B cohort.通过SCAN-B队列分析乳腺癌中mRNA修饰机制的改变。
NAR Cancer. 2025 Sep 3;7(3):zcaf027. doi: 10.1093/narcan/zcaf027. eCollection 2025 Sep.
2
Decoding breast cancer treatment resistance through genetic, epigenetic, and immune-regulatory mechanisms: from molecular insights to translational perspectives.通过遗传、表观遗传和免疫调节机制解读乳腺癌治疗耐药性:从分子见解到转化前景
Cancer Drug Resist. 2025 Jul 21;8:36. doi: 10.20517/cdr.2025.69. eCollection 2025.
3
Integrated Nanopore and short-read RNA sequencing identifies dysregulation of METTL3- m6A modifications in endocrine therapy- sensitive and resistant breast cancer cells.

本文引用的文献

1
Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.核糖体RNA 2'-O-甲基化作为乳腺癌肿瘤间异质性的新层面
NAR Cancer. 2020 Dec 22;2(4):zcaa036. doi: 10.1093/narcan/zcaa036. eCollection 2020 Dec.
2
Nopp140-chaperoned 2'-O-methylation of small nuclear RNAs in Cajal bodies ensures splicing fidelity.Nopp140 伴侣介导的小核仁 RNA 2'-O-甲基化在 Cajal 体中确保剪接保真度。
Genes Dev. 2021 Aug 1;35(15-16):1123-1141. doi: 10.1101/gad.348660.121. Epub 2021 Jul 22.
3
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.
整合纳米孔和短读长RNA测序鉴定内分泌治疗敏感和耐药乳腺癌细胞中METTL3-m6A修饰的失调
Funct Integr Genomics. 2025 Jul 9;25(1):149. doi: 10.1007/s10142-025-01658-2.
4
The Mechanisms, Research Status, and Future Prospects of m6A Modification in Breast Cancer.乳腺癌中m6A修饰的机制、研究现状及未来展望
J Gene Med. 2025 Feb;27(2):e70014. doi: 10.1002/jgm.70014.
5
TGF-β2 Induces Ribosome Activity, Alters Ribosome Composition and Inhibits IRES-Mediated Translation in Chondrocytes.TGF-β2 诱导核糖体活性,改变核糖体组成,并抑制软骨细胞中 IRES 介导的翻译。
Int J Mol Sci. 2024 May 5;25(9):5031. doi: 10.3390/ijms25095031.
6
A Comprehensive Analysis of the Effect of A>I(G) RNA-Editing Sites on Genotoxic Drug Response and Progression in Breast Cancer.A>I(G) RNA编辑位点对乳腺癌基因毒性药物反应及进展影响的综合分析
Biomedicines. 2024 Mar 25;12(4):728. doi: 10.3390/biomedicines12040728.
7
Maturation of small nucleolar RNAs: from production to function.小核仁RNA的成熟:从产生到发挥功能
RNA Biol. 2023 Jan;20(1):715-736. doi: 10.1080/15476286.2023.2254540. Epub 2023 Oct 5.
8
The crucial roles of mA RNA modifications in cutaneous cancers: Implications in pathogenesis, metastasis, drug resistance, and targeted therapies.m⁶A RNA修饰在皮肤癌中的关键作用:对发病机制、转移、耐药性及靶向治疗的影响
Genes Dis. 2022 Apr 1;10(6):2320-2330. doi: 10.1016/j.gendis.2022.03.006. eCollection 2023 Nov.
9
The importance of pseudouridylation: human disorders related to the fifth nucleoside.假尿嘧啶核苷修饰的重要性:与第五种核苷相关的人类疾病。
Biol Futur. 2023 Jun;74(1-2):3-15. doi: 10.1007/s42977-023-00158-3. Epub 2023 Mar 31.
10
METTL3 regulates breast cancer-associated alternative splicing switches.METTL3 调控乳腺癌相关的可变剪接开关。
Oncogene. 2023 Mar;42(12):911-925. doi: 10.1038/s41388-023-02602-z. Epub 2023 Feb 1.
YTHDF2 的抑制会触发 MYC 驱动型乳腺癌中的蛋白毒性细胞死亡。
Mol Cell. 2021 Aug 5;81(15):3048-3064.e9. doi: 10.1016/j.molcel.2021.06.014. Epub 2021 Jul 2.
4
The m6A methyltransferase METTL3 promotes the stemness and malignant progression of breast cancer by mediating m6A modification on SOX2.m6A 甲基转移酶 METTL3 通过介导 SOX2 的 m6A 修饰促进乳腺癌的干性和恶性进展。
J BUON. 2021 Mar-Apr;26(2):444-449.
5
Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.三阴性乳腺癌中m5C RNA甲基化调节因子的预后意义及肿瘤免疫微环境异质性
Front Cell Dev Biol. 2021 Apr 13;9:657547. doi: 10.3389/fcell.2021.657547. eCollection 2021.
6
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.小分子抑制 METTL3 作为治疗髓系白血病的策略。
Nature. 2021 May;593(7860):597-601. doi: 10.1038/s41586-021-03536-w. Epub 2021 Apr 26.
7
CircMETTL3, upregulated in a m6A-dependent manner, promotes breast cancer progression.环状 RNA 甲基转移酶样 3 (METTL3)在 m6A 依赖性方式上调,促进乳腺癌进展。
Int J Biol Sci. 2021 Mar 15;17(5):1178-1190. doi: 10.7150/ijbs.57783. eCollection 2021.
8
-Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis.甲基腺苷调控 KRT7 的 mRNA 稳定性和翻译效率,促进乳腺癌肺转移。
Cancer Res. 2021 Jun 1;81(11):2847-2860. doi: 10.1158/0008-5472.CAN-20-3779. Epub 2021 Apr 1.
9
The expanding world of tRNA modifications and their disease relevance.tRNA 修饰的扩展世界及其与疾病的相关性。
Nat Rev Mol Cell Biol. 2021 Jun;22(6):375-392. doi: 10.1038/s41580-021-00342-0. Epub 2021 Mar 3.
10
Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer.N6-甲基腺苷调节剂对三阴性乳腺癌进展和预后的影响。
Front Genet. 2021 Jan 28;11:580036. doi: 10.3389/fgene.2020.580036. eCollection 2020.